Activation of Human Meprin-α in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System
The activation of latent proenzymes is an important mechanism for the regulation of localized proteolytic activity. Human meprin-α, an astacin-like zinc metalloprotease expressed in normal colon epithelial cells, is secreted as a zymogen into the intestinal lumen. Here, meprin is activated after pr...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2002-10, Vol.277 (43), p.40650 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The activation of latent proenzymes is an important mechanism for the regulation of localized proteolytic activity. Human
meprin-α, an astacin-like zinc metalloprotease expressed in normal colon epithelial cells, is secreted as a zymogen into the
intestinal lumen. Here, meprin is activated after propeptide cleavage by trypsin. In contrast, colorectal cancer cells secrete
meprin-α in a non-polarized way, leading to accumulation and increased activity of meprin-α in the tumor stroma. We have analyzed
the activation mechanism of promeprin-α in colorectal cancer using a co-culture model of the intestinal mucosa composed of
colorectal adenocarcinoma cells (Caco-2) cultivated on filter supports and intestinal fibroblasts grown in the companion dish.
We provide evidence that meprin-α is activated by plasmin and show that the presence of plasminogen in the basolateral compartment
of the co-cultures is sufficient for promeprin-α activation. Analysis of the plasminogen-activating system in the co-cultures
revealed that plasminogen activators produced and secreted by fibroblasts converted plasminogen to active plasmin, which in
turn generated active meprin-α. This activation mechanism offers an explanation for the observed meprin-α activity in the
tumor stroma, a prerequisite for a potential role of this protease in colorectal cancer. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M206203200 |